Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 5, 2013, Pages 342-349

  Eskandari Nasab, Ebrahim ^a,b   Sepanjnia, Adel ^c   Moghadampour, Mehdi ^b   Hadadi Fishani, Mehdi ^b   Rezaeifar, Alireza ^d   Asadi Saghandi, Abolghasem ^e   Sadeghi Kalani, Behrooz ^c   Manshadi, Mahdi Dehghan ^e   Pourrajab, Fatemeh ^e   Pourmasoumi, Hossein ^d  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CagA; Helicobacter pylori; IL 12; IL 13; VacA

Indexed keywords

CAGA PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; VACUOLATING TOXIN;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; COHORT STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-12; INTERLEUKIN-13; MIDDLE AGED; PHENOTYPE;

EID: 84876247957     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.737930     Document Type: Article

References (51)

1. Varbanova M, Malfertheiner P. Bacterial load and degree of gastric mucosal infl ammation in Helicobacter pylori infection . Dig Dis 2011; 29: 592-9.
2. D'E lios MM, Andersen LP. Infl ammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 2009; 14: 21-8.
3. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-33.
4. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005; 50: 2075-80.
5. Terradot L, Waksman G. Architecture of the Helicobacter pylori Cag-type IV secretion system. FEBS J 2011; 278: 1213-22.
6. Molnar B, Galamb O, Sipos F, Leiszter K, Tulassay Z. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis 2010; 28: 604-8.
7. Ozen A, Ertem D, Pehlivanoglu E. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. JPediatr Gastroenterol Nutr 2006; 42: 398-404.
8. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specifi c Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91: 1785-8.
9. Jafarzadeh A, Rezayati MT, Nemati M. Specifi c serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol 2007; 13: 3117-21.
10. D'E lios MM, Montecucco C, de Bernard M. VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric infl ammation. Clin Chim Acta 2007; 381: 32-8.
11. Shirasaka D, Aoyama N, Satonaka K, Shirakawa K, Yoshida H, Sakai T, et al. Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan. Dig Dis Sci 2000; 45: 789-95.
12. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7: 629-41.
13. Wen S, Moss S F. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282: 1-8.
14. Queiroz DM, Cunha RP, Saraiva IE, Rocha AM. Helicobacter pylori virulence factors as tools to study human migrations. Toxicon 2010; 56: 1193-7.
15. Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 1999; 117: 316-23.
16. Garrote JA, Gomez-Gonzalez E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinfl ammatory cytokine network. JPediatr Gastroenterol Nutr 2008; 47: S27-32.
17. de Bernard M, D'E lios M M. The immune modulating activity of the Helicobacter pylori HP-NAP: friend or foe? Toxicon 2010; 56: 1186-92.
18. Dinarello CA. Interleukin-18 and the pathogenesis of infl ammatory diseases. Semin Nephrol 2007; 27: 98-114.
19. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol Med Microbiol 2007; 50: 157-64.
20. Peluso I, Pallone F, Monteleone G. Interleukin-12 and Th1 immune response in Crohn ' s disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006; 12: 5606-10.
21. Pellicano A, Sebkova L, Monteleone G, Guarnieri G, Imeneo M, Pallone F, et al. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect Immun 2007; 75: 1738-44.
22. Takeshima E, Tomimori K, Teruya H, Ishikawa C, Senba M, D' Ambrosio D, et al. Helicobacter pylori-induced interleukin-12 p40 expression. Infect Immun 2009; 77: 1337-48.
23. D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, Tcells and cytokines: the " dangerous liaisons ". FEMS Immunol Med Microbiol 2005; 44: 113-9.
24. Romero-Adrian TB, Leal-Montiel J, Monsalve-Castillo F, Mengual-Moreno E, McGregor EG, Perini L, et al. Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol 2010; 60: 143-55.
25. Fuss IJ, Strober W. The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Mucosal Immunol 2008; 1: S31-3.
26. Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4-and IL-13-mediated signaling pathways. Sci Signal 2008; 1: pe55.
27. Luzza F, Parrello T, Sebkova L, Pensabene L, Imeneo M, Mancuso M, et al. Expression of proinfl ammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Dig Liver Dis 2001; 33: 14-20. Kayhan B, Arasli M
28. Eren H, Aydemir S, Aktas E, Tekin I. Analysis of peripheral blood lymphocyte phenotypes and Th1/Th2 cytokines profi le in the systemic immune responses of Helicobacter pylori infected individuals. Microbiol Immunol 2008; 52: 531-8.
29. Rauws EA, Tytgat G N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
30. Suriani R, Colozza M, Cardesi E, Mazzucco D, Marino M, Grosso S, et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 2008; 22: 255-8.
31. Parrello T, Monteleone G, Cucchiara S, Monteleone I, Sebkova L, Doldo P, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn ' s disease. JImmunol 2000; 165: 7234-9.
32. Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the infl ammatory bowel disease associated with common variable immunodefi ciency. Gastroenterology 2006; 131: 748-56.
33. Ebrahimi AA, Noshad H, Sadreddini S, Hejazi MS, Mohammadzadeh Sadigh Y, Eshraghi Y, et al. Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in treated rheumatoid arthritis patients. Iran J Immunol 2009; 6: 147-53.
34. Lauwerys BR, Van Snick J, Houssiau FA. Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity . Lupus 2002; 11: 384-7.
35. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinfl ammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus . Lupus 2000; 9: 589-93.
36. Musabak U, Demirkaya S, Genc G, Ilikci RS, Odabasi Z. Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens . Neuroimmunomodulation 2011; 18: 57-66.
37. Tazaki T, Minoguchi K, Yokoe T, Oda N, Hashimoto T, Tanaka A, et al. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma. Cell Immunol 2004; 228: 20-6.
38. Andres S, Schmidt HM, Mitchell H, Rhen M, Maeurer M, Engstrand L. Helicobacter pylori defi nes local immune response through interaction with dendritic cells. FEMS Immunol Med Microbiol 2011; 61: 168-78.
39. Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefi t bacterial growth, and contribute to pathology in mice. JImmunol 2010; 184: 5121-9.
40. Otani K, Watanabe T, Tanigawa T, Okazaki H, Yamagami H, Watanabe K, et al. Anti-infl ammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun 2009; 382: 252-8.
41. Garcia-Gonzalez MA, Lanas A, Wu J, Benito R, Santolaria S, Crusius B, et al. Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease. Hum Immunol 2005; 66: 72-6.
42. Sakai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa K, et al. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specifi c IL18 genotypes. JInfect Dis 2008; 197: 1752-61.
43. Deml L, Aigner M, Decker J, Eckhardt A, Schutz C, Mittl PR, et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect Immun 2005; 73: 4732-42.
44. Obonyo M, Cole SP, Datta SK, Guiney DG. Evidence for interleukin-1- independent stimulation of interleukin-12 and down-regulation by interleukin-10 in Helicobacter pyloriinfected murine dendritic cells defi cient in the interleukin-1 receptor. FEMS Immunol Med Microbiol 2006; 47: 414-9.
45. Hida N, Shimoyama T Jr, Neville P, Dixon MF, Axon AT, Shimoyama T Sr, et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. JClin Pathol 1999; 52: 658-64.
46. Augusto AC, Miguel F, Mendonca S, Pedrazzoli Jr, JGurgueira SA. Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clin Biochem 2007; 40: 615-22.
47. de Jonge R, Kusters JG, Timmer MS, Gimmel V, Appelmelk BJ, Bereswill S, et al. The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett 2001; 196: 235-8.
48. Yokota K, Kobayashi K, Kawahara Y, Hayashi S, Hirai Y, Mizuno M, et al. Gastric ulcers in SCID mice induced by Helicobacter pylori infection after transplanting lymphocytes from patients with gastric lymphoma. Gastroenterology 1999; 117: 893-9.
49. Thomson AB, Appleman S, Keelan M, Wallace J L. Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. Dig Dis Sci 2003; 48: 308-14.
50. Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, et al. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinfl ammatory H. pyloriinduced gastric pathology. Infect Immun 2009; 77: 2147-58.
51. Marotti B, Rocco A, De Colibus P, Compare D, de Nucci G, Staibano S, et al. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Dig Liver Dis 2008; 40: 240-7.